These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 30552801)

  • 21. Real-life data on long-term follow-up of patients successfully treated with percutaneous tibial nerve stimulation.
    Bianchi D; Iacovelli V; Parisi I; Petta F; Gaziev G; Topazio L; Bove P; Vespasiani G; Finazzi Agrò E
    Minerva Urol Nephrol; 2021 Apr; 73(2):260-264. PubMed ID: 31487975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous tibial nerve stimulation versus electrical stimulation with pelvic floor muscle training for overactive bladder syndrome in women: results of a randomized controlled study.
    Scaldazza CV; Morosetti C; Giampieretti R; Lorenzetti R; Baroni M
    Int Braz J Urol; 2017; 43(1):121-126. PubMed ID: 28124534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Posterior tibial nerve stimulation vs parasacral transcutaneous neuromodulation for overactive bladder in children.
    Barroso U; Viterbo W; Bittencourt J; Farias T; Lordêlo P
    J Urol; 2013 Aug; 190(2):673-7. PubMed ID: 23422257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous Tibial Nerve Stimulation in the Office Setting: Real-world Experience of Over 100 Patients.
    Sirls ER; Killinger KA; Boura JA; Peters KM
    Urology; 2018 Mar; 113():34-39. PubMed ID: 29196071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Percutaneous Tibial Nerve Stimulation Therapy for Overactive Bladder Syndrome: Clinical Effectiveness, Urodynamic, and Durability Evaluation.
    Del Río-Gonzalez S; Aragon IM; Castillo E; Milla-España F; Galacho A; Machuca J; Lara MF; Herrera-Imbroda B
    Urology; 2017 Oct; 108():52-58. PubMed ID: 28687483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness and durability of solifenacin versus percutaneous tibial nerve stimulation versus their combination for the treatment of women with overactive bladder syndrome: a randomized controlled study with a follow-up of ten months.
    Vecchioli-Scaldazza C; Morosetti C
    Int Braz J Urol; 2018; 44(1):102-108. PubMed ID: 29064651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous tibial nerve stimulation in the treatment of refractory overactive bladder syndrome: is maintenance treatment necessary?
    van der Pal F; van Balken MR; Heesakkers JP; Debruyne FM; Bemelmans BL
    BJU Int; 2006 Mar; 97(3):547-50. PubMed ID: 16469023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcutaneous posterior tibial nerve stimulation versus extended release oxybutynin in overactive bladder patients. A prospective randomized trial.
    Manríquez V; Guzmán R; Naser M; Aguilera A; Narvaez S; Castro A; Swift S; Digesu GA
    Eur J Obstet Gynecol Reprod Biol; 2016 Jan; 196():6-10. PubMed ID: 26645117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of idiopathic overactive bladder in women: Transcutaneous tibial nerve stimulation alone versus combined with pelvic floor muscle training].
    Baati R; Balhi S; Saadi A; Kraiem R; Kennou B; Ayed H; Chebil M
    Prog Urol; 2020 Dec; 30(17):1126-1133. PubMed ID: 32682849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP study.
    Peters KM; Carrico DJ; MacDiarmid SA; Wooldridge LS; Khan AU; McCoy CE; Franco N; Bennett JB
    Neurourol Urodyn; 2013 Jan; 32(1):24-9. PubMed ID: 22674493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome: Randomized control trial.
    Ramírez-García I; Blanco-Ratto L; Kauffmann S; Carralero-Martínez A; Sánchez E
    Neurourol Urodyn; 2019 Jan; 38(1):261-268. PubMed ID: 30311692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solifenacin succinate versus percutaneous tibial nerve stimulation in women with overactive bladder syndrome: results of a randomized controlled crossover study.
    Vecchioli-Scaldazza C; Morosetti C; Berouz A; Giannubilo W; Ferrara V
    Gynecol Obstet Invest; 2013; 75(4):230-4. PubMed ID: 23548260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-inferior and more feasible transcutaneous tibial nerve stimulation in treating overactive bladder: A systematic review and meta-analysis.
    Alomari MS; Abdulhamid AS; Ghaddaf AA; Alshareef KM; Haneef AK; AlQuhaibi MS; Banjar RA
    Int J Urol; 2022 Oct; 29(10):1170-1180. PubMed ID: 35711082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcutaneous tibial nerve electrical stimulation versus vaginal electrical stimulation in women with overactive bladder syndrome: Is there a role for short-term interventions?
    Nunes JMO; Gregório EP; Moreira ECH; Hazime FA; Averbeck MA; de Almeida SHM
    Neurourol Urodyn; 2023 Jun; 42(5):1101-1110. PubMed ID: 37042223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of refractory idiopathic overactive bladder: intradetrusor injection of botulinum toxin type A versus posterior tibial nerve stimulation.
    Sherif H; Khalil M; Omar R
    Can J Urol; 2017 Jun; 24(3):8838-8846. PubMed ID: 28646940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical efficacy of transcutaneous tibial nerve stimulation (TTNS) versus sham therapy (part I) and TTNS versus percutaneous tibial nerve stimulation (PTNS) (part II) on the short term in children with the idiopathic overactive bladder syndrome: protocol for part I of the twofold double-blinded randomized controlled TaPaS trial.
    Ghijselings L; Renson C; Van de Walle J; Everaert K; Spinoit AF
    Trials; 2021 Apr; 22(1):247. PubMed ID: 33810804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of percutaneous and transcutaneous posterior tibial nerve stimulation on idiopathic overactive bladder and interstitial cystitis/painful bladder syndrome: A systematic review and meta-analysis.
    Ghavidel-Sardsahra A; Ghojazadeh M; Rahnama'I MS; Naseri A; Yazdandoost S; Khezerloo T; Seyedi-Sahebari S; Hosseinifard H; Vahed N; Mostafaei H; Salehi-Pourmehr H; Hajebrahimi S
    Neurourol Urodyn; 2022 Feb; 41(2):539-551. PubMed ID: 35032328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient preferences for treating refractory overactive bladder in the UK.
    Hashim H; Beusterien K; Bridges JF; Amos K; Cardozo L
    Int Urol Nephrol; 2015 Oct; 47(10):1619-27. PubMed ID: 26347077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of refractory overactive bladder in children by transcutaneous posterior tibial nerve stimulation: A controlled study.
    Boudaoud N; Binet A; Line A; Chaouadi D; Jolly C; Fiquet CF; Ripert T; Merol ML
    J Pediatr Urol; 2015 Jun; 11(3):138.e1-10. PubMed ID: 25979217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of an implant technique and early experience using a novel implantable pulse generator with a quadripolar electrode array at the tibial nerve for refractory overactive bladder.
    Sirls LT; Schonhoff A; Waldvogel A; Peters KM
    Neurourol Urodyn; 2023 Feb; 42(2):427-435. PubMed ID: 36573835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.